| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |